Our results provided a systematic view of cancer origins, and suggested that restoring and maintaining the balance of inflammation and their mediators (e.g., AnxA1/FPRs signaling) may represent a novel approach to control the evolution of precancerous lesions and mitigate the risk for cancer development. Here, ANXA1 is linked to cancer.